Puma Biotechnology Balance Sheet
Puma Biotechnology's total assets for Q4 2025 were $216.30M, an increase of 6.63% from the previous quarter. PBYI total liabilities were $85.96M for the fiscal quarter, a -1.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.